The Hydration Pharmaceuticals Company (ASX:HPC)
ASX announcement history & article coverage
Transparent by design.
Announcments by The Hydration Pharmaceuticals Company (ASX:HPC) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Initial Director's Interest Notices
Final Director's Interest Notices
Change in substantial holding
Becoming a substantial holder
Change in substantial holding
Change in substantial holding
Becoming a substantial holder
Completion of Share Issue and Cleansing Statement
Application for quotation of securities - HPC
Application for quotation of securities - HPC
Proposed issue of securities - HPC
Capital raising, board renewal and management changes
Hydralyte USA raises A$392k, appoints new board members, and plans cost cuts
Results of Meeting
2026 AGM CEO Presentation
Notice of initial substantial holder
Ceasing to be a substantial holder
Change in substantial holding
Reinstatement to Quotation
HPC Reinstated to ASX Quotation from 4 May 2026
Relodgement of Annual Report
Hydration Pharmaceuticals relodges FY25 Annual Report amid trading halt; reports $2.86M loss and ongoing cost-cutting
Q1 FY26 Quarterly Activities Report (App 4C)
Hydralyte USA posts Q1 sales growth and cost savings, eyes strategic M&A and financing
Letter to Shareholders regarding Annual General Meeting
Notice of Annual General Meeting/Proxy Form